Evidence map›Paper›PMID 29404888›Full record

ArticleMolecular and cellular biochemistry2018

HIV-1 Nef CAWLEAQ motif: a regulator of monocytes invasion through ENO1 modulation.

Reshu Saxena, Umesh Kumar Vekariya, Pradeep Kumar, Amit Kumar Tripathi, Jimut Kanti Ghosh, Raj Kamal Tripathi

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Reshu SaxenaToxicology Division, Central Drug Research Institute (Council of Scientific & Industrial Research), Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, U.P., 226031, India.
Umesh Kumar VekariyaToxicology Division, Central Drug Research Institute (Council of Scientific & Industrial Research), Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, U.P., 226031, India.
Pradeep KumarToxicology Division, Central Drug Research Institute (Council of Scientific & Industrial Research), Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, U.P., 226031, India.
Amit Kumar TripathiMolecular and Structural Biology Division, Central Drug Research Institute (Council of Scientific & Industrial Research), Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, U.P., 226031, India.
Jimut Kanti GhoshMolecular and Structural Biology Division, Central Drug Research Institute (Council of Scientific & Industrial Research), Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, U.P., 226031, India.
Raj Kamal TripathiToxicology Division, Central Drug Research Institute (Council of Scientific & Industrial Research), Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, U.P., 226031, India. rk_tripathi@cdri.res.in.ORCID http://orcid.org/0000-0002-7397-8363
Central Drug Research Institute · IN

Funding

Central Drug Research Institute BSC0111
6 · The paper itself

Abstract

HIV-1 transmission and spread involves significant host-virus interaction. Possible targets for obstacle of HIV-1 lie at the site of mucosal barriers. Thus a better understanding of how HIV-1 infects target cells at such sites and leads their invasion is required, with prime focus on the host determinants regulating HIV-1 spread. For the viral infectivity and pathogenicity, HIV-1 Nef facilitates immune evasion through protein-protein interactions within host cell. HIV-1 Nef is significant for viral infectivity and pathogenicity. It enhances HIV-1 replication, facilitating immune evasion by interacting with various host factors and altering cellular pathways via multiple protein-protein interactions. In this study, HIV-1 Nef forms with specific mutations, revealing sequence variability, were studied for their effects in human SupT1 T cell line and (THP-1) monocyte-macrophage cell line. Proteins being downregulated by Nef in SupT1 were further observed in THP-1, and interestingly two host proteins' (ENO-1 and VDAC1) expression was found to be cell lineage specific, being stimulatory in macrophages/monocytes and inhibitory in T cells. Cell migration, invasion and ADP release studies were employed to determine the biological function affected by Nef-mediated regulation of these two host proteins. ENO1-regulated function: cell invasion was enhanced in THP-1 cells, but was inhibited in SupT1 cells by Nef RP01. In addition, the modulation of proteins and cell invasion remained unaffected by a Nef RP14. These results indicated that regulation of host protein expression and invasive property of host cells by Nef was sequence specific, suggesting involvement of a particular motif of Nef. To precisely determine this site, we designed a heptapeptide including the CAWLEAQ-regulating sequence of Nef. Macrophages/monocytes being the major cells affected by HIV-1 at mucosal barriers were particularly investigated by the peptide. The peptide led to reversal of differential expressions of ENO1 in both SupT1 and THP-1 and inhibition of enhanced invasiveness in THP-1 cells. Further AP-1 was identified as a factor involved in this Nef-mediated regulation of host proteins. Together these findings suggest a possible mechanism of host invasion by HIV-1 through the CAWLEAQ motif of Nef-mediated regulation of ENO1 and identify a potential therapeutic target for HIV-1 entry at mucosal barriers.

Indexed as

Virus InternalizationAmino Acid MotifsBiomarkers, TumorDNA-Binding ProteinsHIV-1HumansMonocytesMutationnef Gene Products, Human Immunodeficiency VirusPhosphopyruvate HydrataseTHP-1 CellsTumor Suppressor ProteinsBiomarkers, TumorDNA-Binding ProteinsENO1 protein, humannef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1Phosphopyruvate HydrataseTumor Suppressor ProteinsAP1Cell invasionHIV-1 NefHost–virus interactionNef variants

Identifiers

PMID29404888
OpenAlexW2787006475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.